J.M. García et al. / Inorganica Chimica Acta 414 (2014) 250–256
251
way, it has been reported the study of the indenyl ruthenium
derivative
CDCl3, 25 °C): d 66.15 (d, JPRh = 158.3 Hz). 1H NMR (300.13 MHz,
3
CDCl3, 25 °C): d 1.31 (d, JHH = 6.9 Hz, 12H, CH3NiPr), 1.95 (d,
[Ru-(g
5-C9H7){
j
3(P,C,C)-Ph2PCH2CH@CH2}(PPh3)][PF6] [4f].
2JPH = 8.9 Hz, 4H, PCH2), 2.29 (m, 4H, CH2COD), 2.49 (m, 2H, CH2COD),
2.86 (m, 2H, CH2COD), 3.63 (brs, 2H, CH@CHCOD), 4.04 (m, 2H,
CHNiPr), 5.11 (brs, 2H, @CH2), 5.14 (brs, 2H, @CH2), 5.33 (brs, 2H,
CH@CHCOD), 6.08 (m, 2H, CH@).13C{1H} NMR (75.47 MHz, CDCl3,
25 °C): d 28.42 (s, 4C, CH3NiPr), 32.52 (s, 2C, CH2COD), 32.81 (s, 2C,
In the present work we report on the synthesis, characterization
and dynamic behavior of cationic rhodium complexes of the type
[Rh(COD){j
3(P,C,C)-RP(CH2CH@CH2)2}][BF4] (R = tBu 3a, Ph 3b,
iPr2N 3c). The hemilabile properties of diallylphosphine ligands
are showed by the reversible displacement of the coordinated allylic
double bond by acetonitrile addition, which can be removed under
vacuum. DFT calculations have been performed in order to better
explain the experimental observations.
2
CH2COD), 33.27 (d, JCP = 2.4 Hz, 2C, PCH2), 51.90 (d, JCP = 7.4 Hz,
2C, CHNiPr), 67.32 (d, JCRh = 14.2 Hz, 2C, CH@CHCOD), 103.46 (dd,
3
2JCP = 6.8 Hz, JCRh = 12.9 Hz, 2C, CH@CHCOD), 118.24 (d, JCP = 10.8 -
Hz, 2C, @CH2), 131.84 (s, 2C, CH@). Anal. Calc. for C20H36ClNPRh:
C, 52.25; H, 7.83; N, 3.04. Found: C, 51.93; H, 8.03; N, 3.07%.
2. Experimental
2.3. Synthesis of [Rh(COD){
3a, Ph 3b, Pr2N 3c)
j
3(P,C,C)-RP(CH2CH@CH2)2}][BF4] (R = tBu
i
2.1. General information
A solution of the complexes2a–c (0.22 mmol) in THF (20 mL) was
treated with AgBF4 (42.4 mg, 0.22 mmol), and the mixture was stir-
red for 1 h at ꢀ80 °C. The solution was evaporated to dryness. The
resulting solid was extracted with dichloromethane (2 ꢁ 20 mL)
and vacuum-dried to give the complex as orange solid which was
washed with diethyl ether (20 mL) and vacuum-dried. R = tBu 3a:
(88 mg, 86%); 31P{1H} NMR (202.41 MHz, CD2Cl2, 25 °C): d ꢀ 68.22
(d, JPRh = 110.1 Hz). 1H NMR (500.03 MHz, CD2Cl2, 25 °C): d 1.21 (d,
All manipulations were performed under an inert atmosphere
of argon by using standard Schlenk techniques. Dry, oxygen-free
solvents were employed. The elemental analysis was performed
(C, H, N) on
a model EA1108 Fisons elemental analyzer.
1H, 13C{1H}, 31P{1H} NMR spectra were recorded on Bruker, Avance
500 or Avance 300 spectrometers. 1H, 13C{1H} NMR chemical shifts
are reported in ppm relative to Me4Si as external standard. 31P{1H}
NMR chemical shifts are expressed in ppm relative to 85% H3PO4.
Diallylphosphines were prepared by published methods [6,7]. Di-
2JPH = 16.1 Hz, 9H, CH3 Bu), 2.27–2.59 (m, 8H, CH2COD), 2.96–3.07
t
(m, 4H, PCH2), 4.84 (dd, 3JHH = 9.5 Hz, 4JPH = 3.5 Hz, 2H, @CH2), 5.06
mer complex [Rh2(l-Cl)2(COD)2] was purchased from Strem
Chemicals. Other chemicals were purchased from Sigma–Aldrich
Co.
3
4
(dd, JHH
= 16.5 Hz, JPH = 2.9 Hz, 2H, @CH2), 5.25 (brs, 2H,
CH@CHCOD), 5.79–5.89 (m, 2H, CH@). 13C{1H} NMR (125.74 MHz,
CD2Cl2, 25 °C): d 25.99 (d, JCP = 20.5 Hz, 2C, PCH2), 26.91 (d,
2JCP = 3.8 Hz, 3C, CH3 Bu), 29.23 (s, 2C, CH2COD), 31.69 (d, JCP = 17.0 Hz,
t
2.2. Synthesis of complexes
PCtBu), 32.03 (s, CH2COD), 32.05 (s, CH2COD), 90.99 (d, JCRh = 10.3 Hz,
2
2C, CH@CHCOD), 105.86 (dd, JCP = 6.0 Hz, JCRh = 8.5 Hz, 2C,
CH@CHCOD), 107.23 (brs, @CH2), 107.94 (d, JCP = 7.6 Hz, @CH2),
113.07 (d, JCP = 7.4 Hz, 2C, CH@). Anal. Calc. for C18H31BF4PRh: C,
3
2.2.1. Synthesis of [RhCl(COD){
Ph 2b, Pr2N 2c)
j
1(P)-RP(CH2CH@CH2)2}] (R = tBu 2a,
i
2
To a solution of [Rh2(
l
-Cl)2(COD)2] (100 mg, 0.203 mmol) in
46.18; H, 6.62. Found: C, 45.20; H, 6.56%. R = Ph Mixture 3b and
3b-THF: The more important signals in 31P{1H} NMR (202.41 MHz,
CDCl3, 25 °C): d 2.9 (d, JPRh = 143.6 Hz for 3b) and 15.4 (d,
JPRh = 159.9 Hz for 3b-THF) and 13C{1H} NMR (125.74 MHz, CDCl3,
25 °C): d = 25.6 (CH2THFuncoordinated), 26.5 (CH2THFcoordinated), 67.9
(OACH2THFuncoordinated), 70.6 (OACH2THFcoordinated), 107.0 (d,
3JCP = 7.6 Hz, @CH2), 105.6 (d, 2JCP = 2.4 Hz, CH@), 120.7
CH2Cl2 (20 mL) was added dropwise a solution of the correspond-
ing diallylphosphine 1a–c (0.426 mmol) in 10 mL of CH2Cl2. The
solution was stirred for 1 h at ꢀ80 °C. The solution was evaporated
to dryness to give a yellow solid, which was washed with hexane
(5 mL) and vacuum-dried. R = tBu 2a: (172 mg, 97%); 31P{1H}
NMR (121.49 MHz, CDCl3, 25 °C): d 24.71 (d, JPRh = 146.8 Hz). 1H
2
2
NMR (300.13 MHz, CDCl3, 25 °C): d 1.25 (d, JPH = 13.4 Hz, 9H,
(brs, @CH2uncoordinated), 129.4 (d, JCP = 10.1 Hz, CH@). R = iPr2N 3c:
CH3 Bu), 1.88 (brs, 4H, CH2COD), 2.15–2.36 (m, 6H, CH2COD, PCH2),
(90 mg, 80%). 31P{1H} NMR (202.41 MHz, CD2Cl2, 25 °C): d – 23.79
(d, JPRh = 104.4 Hz). 1H NMR (500.03 MHz, CD2Cl2, 25 °C): d 1.17 (d,
t
2.64–2.73 (m, 2H, PCH2), 3.66 (brs, 2H, CH@CHCOD), 5.03–5.10
(m, 4H, @CH2), 5.22 (brs, 2H, CH@CHCOD), 5.87–6.02 (m, 2H,
3JHH = 6.6 Hz, 12H, CH3N Pr), 2.24–2.44 (m, 8H, CH2COD), 2.93 (t, 4H,
i
CH@). 13C{1H} NMR (75.47 MHz, CDCl3, 25 °C):
d
25.42 (d,
JPH = 7.1 Hz, PCH2), 3.34 (d, JHH = 5.9 Hz, 2H,CHN Pr), 4.53 (dd,
3
i
JCP = 18.2 Hz, 2C, PCH2), 28.33 (s, 2C, CH2COD), 29.27 (d, 2JCP = 3.9 Hz,
3JHH = 16.3 Hz, JHH = 9.0 Hz, 4H, @CH2), 5.00 (brs, 1H, CH@COD),
3
3C, CH3 Bu), 33.24 (s, 2C, CH2COD), 34.02 (d, JCP = 17.9 Hz, PCtBu),
5.28 (brs, 1H, CH@COD), 5.87 (brs, 2H, CH@). 13C{1H} (125.74 MHz,
CD2Cl2, 25 °C): d 24.93 (s, CH3NiPr), 29.05 (s, 2C, CH2COD), 31.97 (s,
CH2COD), 32.00 (s, CH2COD), 34.51 (d, JCP = 27.5 Hz, PCH2), 47.30 (s,
CHNiPr), 89.15 (d, JCRh = 7.6 Hz, CH@CHCOD), 100.18 (brs, @CH2),
107.56 (d, 2JCP = 7.6 Hz, CH@), 107.88 (dd, 2JCP = 5.0 Hz, JCRh = 9.9 Hz,
2C, CH@CHCOD). Anal. Calc. for C20H36NBF4PRh: C, 46.99; H, 7.04; N,
2.74. Found: C, 44.91; H, 7.06; N, 2.86%. 31P{1H} NMR
(202.41 MHz, CD2Cl2, ꢀ90 °C): d – 22.79 (d, JPRh = 100.7 Hz). 1H
NMR (500.03 MHz, CD2Cl2, ꢀ90 °C): d 0.99 (brs, 9H, CH3NiPr), 1.41
(brs, 3H, CH3NiPr), 2.07–2.63 (m, 10H, PCH2uncoordinated, CH2COD),
t
2
68.00 (d, JCRh = 13.8 Hz, 2C, CH@CHCOD), 103.36 (dd, JCP = 7.2 Hz,
3
JCRh = 11.9 Hz, 2C, CH@CHCOD), 118.41 (d, JCP = 9.6 Hz, 2C, @CH2),
2
132.16 (d, JCP = 4.7 Hz, 2C, CH@). Anal. Calc. for C18H31ClPRh: C,
51.88; H, 7.44. Found: C, 51.72; H, 7.17%. R = Ph 2b: (182 mg,
98%); 31P{1H} NMR (121.49 MHz, CDCl3, 25 °C): d = 14.15
(d, JPRh = 148.4 Hz). 1H NMR (300.13 MHz, CDCl3, 25 °C): d = 1.85–
1.99 (m, 4H, CH2COD), 2.29 (brs, 4H, PCH2), 2.78–3.01 (m, 4H,
CH2COD), 3.23 (brs, 2H, CH@CHCOD), 5.09–5.16 (m, 4H, @CH2),
5.36 (brs, 2H, CH@CHCOD), 5.79–5.95 (m, 2H, CH@), 7.33–7.35 (m,
3H, CHAr), 7.50–7.57 (m, 2H, CHAr). 13C{1H} NMR (75.47 MHz,
CDCl3, 25 °C): d = 28.46 (s, 2C, CH2COD), 29.98 (d, JCP = 23.7 Hz, 2C,
PCH2), 32.89 (s, 2C, CH2COD), 69.42 (d, JCRh = 13.8 Hz, 2C,
CH@CHCOD), 104.54 (dd, 2JCP = 6.8 Hz, JCRh = 11.9 Hz, 2C,
3
3.20 (brs, 4H, PCH2coordinated, CHNiPr), 3.67 (d, JHH = 13.9 Hz, 1H,
@CH2coordinated), 3.77 (brs, 1H, @CH2coordinated), 4.48 (brs, 1H,
CH@COD), 4.69 (brs, 1H, CH@COD), 5.20 (brs, 2H, @CH2uncoordinated),
5.52 (brs, 1H, CH@COD), 5.64 (brs, 2H, CH@COD, CH@uncoordinated),
5.98 (brs, 1H, CH@Coordinated). 13C{1H} NMR (125.74 MHz, CD2Cl2,
ꢀ90 °C): d 20.80 (brs, CH3NiPr), 21.49 (brs, CH3NiPr), 25.84 (brs,
CH3NiPr), 27.11 (s, CH2COD), 28.73 (s, CH2COD), 30.05 (s, CH2COD),
31.07 (brs, CH3NiPr), 31.97 (s, CH2COD), 32.35 (d, JCP = 36.3 Hz,
PCH2uncoordinated), 34.63 (s, CH2COD), 35.50 (d, JCP = 20.3 Hz,
3
CH@CHCOD), 118.78 (d, JCP = 10.3 Hz, 2C, @CH2), 128.17 (d,
3JCP = 8.8 Hz, 2C, CHAr), 129.70 (s, CHAr), 130.71 (brs, Cipso), 131.09
2
2
(d, JCP = 4.7 Hz, 2C, CH@), 131.36 (d, JCP= 8.7 Hz, 2C, CHAr). Anal.
Calc. for C20H27ClPRh: C, 54.99; H, 6.18. Found: C, 52.76; H,
6.17%. R = iPr2N 2c: (192 mg, 98%); 31P{1H} NMR (121.49 MHz,